Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

Role of Cripto-1 during epithelial-to-mesenchymal transition in development and cancer.

Rangel MC, Karasawa H, Castro NP, Nagaoka T, Salomon DS, Bianco C.

Am J Pathol. 2012 Jun;180(6):2188-200. doi: 10.1016/j.ajpath.2012.02.031. Epub 2012 Apr 26. Review.

2.

The multifaceted role of the embryonic gene Cripto-1 in cancer, stem cells and epithelial-mesenchymal transition.

Klauzinska M, Castro NP, Rangel MC, Spike BT, Gray PC, Bertolette D, Cuttitta F, Salomon D.

Semin Cancer Biol. 2014 Dec;29:51-8. doi: 10.1016/j.semcancer.2014.08.003. Epub 2014 Aug 19. Review.

3.

Nodal and Cripto-1: embryonic pattern formation genes involved in mammary gland development and tumorigenesis.

Kenney NJ, Adkins HB, Sanicola M.

J Mammary Gland Biol Neoplasia. 2004 Apr;9(2):133-44. Review.

PMID:
15300009
4.

Msx2 induces epithelial-mesenchymal transition in mouse mammary epithelial cells through upregulation of Cripto-1.

di Bari MG, Ginsburg E, Plant J, Strizzi L, Salomon DS, Vonderhaar BK.

J Cell Physiol. 2009 Jun;219(3):659-66. doi: 10.1002/jcp.21712.

5.

The EGF-CFC family: novel epidermal growth factor-related proteins in development and cancer.

Saloman DS, Bianco C, Ebert AD, Khan NI, De Santis M, Normanno N, Wechselberger C, Seno M, Williams K, Sanicola M, Foley S, Gullick WJ, Persico G.

Endocr Relat Cancer. 2000 Dec;7(4):199-226. Review.

6.

Snail-mediated Cripto-1 repression regulates the cell cycle and epithelial-mesenchymal transition-related gene expression.

Pilli VS, Gupta K, Kotha BP, Aradhyam GK.

FEBS Lett. 2015 May 8;589(11):1249-56. doi: 10.1016/j.febslet.2015.04.005. Epub 2015 Apr 15.

7.

Cripto-1 ablation disrupts alveolar development in the mouse mammary gland through a progesterone receptor-mediated pathway.

Klauzinska M, McCurdy D, Rangel MC, Vaidyanath A, Castro NP, Shen MM, Gonzales M, Bertolette D, Bianco C, Callahan R, Salomon DS, Raafat A.

Am J Pathol. 2015 Nov;185(11):2907-22. doi: 10.1016/j.ajpath.2015.07.023. Epub 2015 Oct 1.

8.

CRIPTO overexpression promotes mesenchymal differentiation in prostate carcinoma cells through parallel regulation of AKT and FGFR activities.

Terry S, El-Sayed IY, Destouches D, Maillé P, Nicolaiew N, Ploussard G, Semprez F, Pimpie C, Beltran H, Londono-Vallejo A, Allory Y, de la Taille A, Salomon DS, Vacherot F.

Oncotarget. 2015 May 20;6(14):11994-2008.

9.

Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression.

Micalizzi DS, Farabaugh SM, Ford HL.

J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):117-34. doi: 10.1007/s10911-010-9178-9. Epub 2010 May 19. Review.

10.

Cripto-1: an embryonic gene that promotes tumorigenesis.

de Castro NP, Rangel MC, Nagaoka T, Salomon DS, Bianco C.

Future Oncol. 2010 Jul;6(7):1127-42. doi: 10.2217/fon.10.68. Review.

PMID:
20624125
11.

Role of Cripto-1 in stem cell maintenance and malignant progression.

Bianco C, Rangel MC, Castro NP, Nagaoka T, Rollman K, Gonzales M, Salomon DS.

Am J Pathol. 2010 Aug;177(2):532-40. doi: 10.2353/ajpath.2010.100102. Epub 2010 Jul 8. Review.

12.

Epithelial mesenchymal transition is a characteristic of hyperplasias and tumors in mammary gland from MMTV-Cripto-1 transgenic mice.

Strizzi L, Bianco C, Normanno N, Seno M, Wechselberger C, Wallace-Jones B, Khan NI, Hirota M, Sun Y, Sanicola M, Salomon DS.

J Cell Physiol. 2004 Nov;201(2):266-76.

PMID:
15334661
13.

Genetic variants modulating CRIPTO serum levels identified by genome-wide association study in Cilento isolates.

Ruggiero D, Nappo S, Nutile T, Sorice R, Talotta F, Giorgio E, Bellenguez C, Leutenegger AL, Liguori GL, Ciullo M.

PLoS Genet. 2015 Jan 28;11(1):e1004976. doi: 10.1371/journal.pgen.1004976. eCollection 2015 Jan.

14.

Netrin-1 regulates invasion and migration of mouse mammary epithelial cells overexpressing Cripto-1 in vitro and in vivo.

Strizzi L, Bianco C, Raafat A, Abdallah W, Chang C, Raafat D, Hirota M, Hamada S, Sun Y, Normanno N, Callahan R, Hinck L, Salomon D.

J Cell Sci. 2005 Oct 15;118(Pt 20):4633-43. Epub 2005 Sep 21.

15.

Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis.

Strizzi L, Bianco C, Normanno N, Salomon D.

Oncogene. 2005 Aug 29;24(37):5731-41. Review.

PMID:
16123806
16.

Cripto-independent Nodal signaling promotes positioning of the A-P axis in the early mouse embryo.

Liguori GL, Borges AC, D'Andrea D, Liguoro A, Gonçalves L, Salgueiro AM, Persico MG, Belo JA.

Dev Biol. 2008 Mar 15;315(2):280-9. doi: 10.1016/j.ydbio.2007.12.027. Epub 2007 Dec 31.

17.

Noncanonical TGF-β signaling during mammary tumorigenesis.

Parvani JG, Taylor MA, Schiemann WP.

J Mammary Gland Biol Neoplasia. 2011 Jun;16(2):127-46. doi: 10.1007/s10911-011-9207-3. Epub 2011 Mar 31. Review.

18.

Emerging roles of nodal and Cripto-1: from embryogenesis to breast cancer progression.

Strizzi L, Postovit LM, Margaryan NV, Seftor EA, Abbott DE, Seftor RE, Salomon DS, Hendrix MJ.

Breast Dis. 2008;29:91-103.

19.

Activation of NF-κB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines.

Tsubaki M, Komai M, Fujimoto S, Itoh T, Imano M, Sakamoto K, Shimaoka H, Takeda T, Ogawa N, Mashimo K, Fujiwara D, Mukai J, Sakaguchi K, Satou T, Nishida S.

J Exp Clin Cancer Res. 2013 Sep 5;32:62. doi: 10.1186/1756-9966-32-62.

20.

Cripto-1 activates nodal- and ALK4-dependent and -independent signaling pathways in mammary epithelial Cells.

Bianco C, Adkins HB, Wechselberger C, Seno M, Normanno N, De Luca A, Sun Y, Khan N, Kenney N, Ebert A, Williams KP, Sanicola M, Salomon DS.

Mol Cell Biol. 2002 Apr;22(8):2586-97.

Supplemental Content

Support Center